Surgery Partners, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Surgery Partners, Inc. reported Cash And Cash Equivalents At Carrying Value of $239.90 million for the year ending 2025.

  • Surgery Partners, Inc. showed a decrease of -11.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Surgery Partners, Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q3 2014: $4.39 million | Q1 2015: $56.44 million | Q2 2015: $47.91 million | Q3 2015: $56.85 million | Q4 2015: $57.93 million | Q1 2016: $135.05 million | Q2 2016: $51.60 million | Q3 2016: $55.21 million | Q4 2016: $69.70 million | Q1 2017: $55.97 million | Q2 2017: $57.03 million | Q3 2017: $199.70 million | Q1 2018: $112.82 million | Q2 2018: $96.07 million | Q3 2018: $79.12 million | Q1 2019: $142.50 million | Q2 2019: $117.40 million | Q3 2019: $111.30 million | Q1 2020: $194.60 million | Q2 2020: $326.30 million | Q3 2020: $450.00 million | Q1 2021: $541.90 million | Q2 2021: $464.80 million | Q3 2021: $330.40 million | Q1 2022: $378.90 million | Q2 2022: $227.40 million | Q3 2022: $154.80 million | Q1 2023: $245.50 million | Q2 2023: $177.40 million | Q3 2023: $236.00 million | Q1 2024: $185.20 million | Q2 2024: $213.50 million | Q3 2024: $221.80 million | Q1 2025: $229.30 million | Q2 2025: $250.10 million | Q3 2025: $203.40 million.
  • Over the full 15 years of available data (2012 to 2025), Surgery Partners, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 4,485.2%.
  • Historical annual values: Fiscal year 2025: $239.90 million | Fiscal year 2024: $269.50 million | Fiscal year 2023: $195.90 million | Fiscal year 2022: $282.90 million | Fiscal year 2021: $389.90 million | Fiscal year 2020: $317.90 million | Fiscal year 2019: $92.70 million | Fiscal year 2018: $184.30 million | Fiscal year 2017: $174.91 million | Fiscal year 2017: $214.21 million | Fiscal year 2016: $69.70 million | Fiscal year 2015: $57.93 million | Fiscal year 2014: $74.92 million | Fiscal year 2013: $13.03 million | Fiscal year 2012: $5.23 million.
  • Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: